SCHEMBL6137414

SCHEMBL6137414

N=C(N)NC(=O)c1ccc(N2CCN(C(=O)c3ccc(F)cc3)CC2)c(C(F)(F)F)c1

nearest known ligand 0.48

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
SLC9A1 P19634 3/20 0.48
CYP3A4 P08684 2/20 0.48
CYP2C19 P33261 2/20 0.48
NPY2R P49146 2/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
CYP2C9 P11712 1/20 0.46
MAPT P10636 1/20 0.42
HTT P42858 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
ALDH1A1 P00352 1/20 0.42
HSD11B1 P28845 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7985439 0.95 NPY2R (0.46) SLC9A1CYP3A4CYP2C19NPY2RMEN1
Hydrochloric Acid SCHEMBL6137232 0.91 NPY2R (0.55) SLC9A1CYP3A4CYP2C19NPY2RMEN1
Hydrochloric Acid SCHEMBL7988911 0.87 SLC9A1 (0.48) SLC9A1CYP3A4CYP2C19NPY2RMEN1
Hydrochloric Acid SCHEMBL6137329 0.85 NPY2R (0.51) SLC9A1CYP3A4CYP2C19NPY2RMEN1
Sabiporide SCHEMBL29385812 0.84 SLC9A1 (0.70) SLC9A1CYP3A4CYP2C19NPY2R
Sabiporide SCHEMBL1286662 0.84 SLC9A1 (0.70) SLC9A1CYP3A4CYP2C19NPY2R
SCHEMBL7612077 0.83 MAPT (0.52) SLC9A1CYP3A4CYP2C19MEN1KMT2A
Sabiporide SCHEMBL1286645 0.83 SLC9A1 (0.69) SLC9A1CYP3A4CYP2C19NPY2R
Sabiporide SCHEMBL4901732 0.82 SLC9A1 (0.68) SLC9A1CYP3A4CYP2C19NPY2R
SCHEMBL1763080 0.82 SLC9A1 (0.68) SLC9A1CYP3A4CYP2C19CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1165534-B1 BENZOYLGUANIDINE DERIVATIVES WITH ADVANTAGEOUS PROPERTIES, METHOD FOR PRODUCING THEM AND THEIR USE IN THE PRODUCTION OF MEDICAMENTS BOEHRINGER INGELHEIM PHARMA (DE) 2005-02-02 EP claimed
EP-1165534-A2 BENZOYLGUANIDINE DERIVATIVES WITH ADVANTAGEOUS PROPERTIES, METHOD FOR PRODUCING THEM AND THEIR USE IN THE PRODUCTION OF MEDICAMENTS Boehringer Ingelheim Pharma KG (DE) 2002-01-02 EP disclosed
WO-2000017176-A2 BENZOYLGUANIDINE DERIVATIVES WITH ADVANTAGEOUS PROPERTIES, METHOD FOR PRODUCING THEM AND THEIR USE IN THE PRODUCTION OF MEDICAMENTS BOEHRINGER INGELHEIM PHARMA KG (DE) 2000-03-30 WO disclosed